Top

Published in:

01-08-2007 | Poster presentation

Selective V1a receptor agonists in experimental septic shock

Author: Daniel Traber

Published in: Critical Care | Special Issue 4/2007

Excerpt

Septic shock is caused by hypotension secondary to vasodilation. This hypotension is resistant to fluid resuscitation and requires the use of vasopressor agents. Recently, it was shown that it may be due to a deficiency in the vasopressor hormone arginine–vasopressin (AVP), a mixed V1a/V2 receptor agonist, leading to the clinical use of AVP in septic shock. We tested the hypothesis that the selective V1a receptor agonist FE 202158 is at least as effective as AVP in a sheep model of pneumonia-induced septic shock. …

Title: Selective V1a receptor agonists in experimental septic shock
Author: Daniel Traber
Publication date: 01-08-2007
Publisher: BioMed Central
Published in: Critical Care / Issue Special Issue 4/2007
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/cc6030

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Selective V1a receptor agonists in experimental septic shock

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 4/2007

Cytokine-mediated regulation of renal urea transporters during sepsis

The identification and use of common physiologic monitoring parameters in the care of critically ill patients at risk for sepsis

Microbiological diagnosis of sepsis: comparison between real-time polymerase chain reaction and blood culture techniques

The human antimicrobial peptide LL-37 induces endothelium-dependent vascular smooth muscle relaxation mediated via the lipoxin A4 receptor

The activity of the endothelial Tie-2 receptor modulates ventilation-induced lung injury in septic mice

LL-37 at the local site of streptococcal skin and soft-tissue infections